Sun Country Airlines: How A Broken Execution Led To A Lower Acquisition Premium

Sun Country Airlines remains a buy with a $19.64 target—near-term earnings pressured by fleet/pilot issues, but 2026 recovery ...

Quince Therapeutics: Good Potential In Orphan Disease In Q1 With Platform Potential

Quince Therapeutics (QNCX) rated Buy ahead of Phase 3 NEAT readout in A-T; eDSP targets $1B+ orphan market with strong cash ...
Cowboy State Daily

Trump’s EPA Rejects Closure Of Colorado Power Plant That Burns Wyoming Coal

The Trump administration’s EPA has finalized its rejection of closing a coal-fired power plant in Colorado, drawing sharp ...
EuropaWire

Sanofi Secures European Approval for Disease-Modifying Type 1 Diabetes Therapy

The European Commission has approved Sanofi’s Teizeild as the first disease-modifying therapy in the EU to delay the onset of stage 3 type 1 diabetes in adults and children with stage 2 T1D. Supported ...